GPN Vaccines

About:

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Website: https://gpnvaccines.com/

Twitter/X: GPNVaccines

Top Investors: National Health and Medical Research Council, Shearwater Capital, Forepont Capital Partners, Government of South Australia, Kern Whelan Capital

Description:

GPN Vaccines is a clinical stage biotechnology company developing a Streptococcus pneumoniae vaccine. The company's vaccine is designed to prevent life-threatening pneumonia, bacteremia, and meningitis, as well as otitis media.

Total Funding Amount:

36.1M AUD

Headquarters Location:

Adelaide, South Australia, Australia

Founded Date:

2017-09-19

Founders:

Tim Hirst

Number of Employees:

11-50

Last Funding Date:

2024-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai